157 related articles for article (PubMed ID: 26485505)
1. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis.
Zhou L; Pradhan-Sundd T; Poddar M; Singh S; Kikuchi A; Stolz DB; Shou W; Li Z; Nejak-Bowen KN; Monga SP
Am J Pathol; 2015 Dec; 185(12):3274-89. PubMed ID: 26485505
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-Catenin Signaling Plays a Protective Role in the Mdr2 Knockout Murine Model of Cholestatic Liver Disease.
Pradhan-Sundd T; Kosar K; Saggi H; Zhang R; Vats R; Cornuet P; Green S; Singh S; Zeng G; Sundd P; Nejak-Bowen K
Hepatology; 2020 May; 71(5):1732-1749. PubMed ID: 31489648
[TBL] [Abstract][Full Text] [Related]
3. γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.
Wickline ED; Du Y; Stolz DB; Kahn M; Monga SP
Neoplasia; 2013 Apr; 15(4):421-34. PubMed ID: 23555187
[TBL] [Abstract][Full Text] [Related]
4. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
[TBL] [Abstract][Full Text] [Related]
5. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
[TBL] [Abstract][Full Text] [Related]
6. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
7. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
[TBL] [Abstract][Full Text] [Related]
8. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
10. 150th Anniversary Series: Desmosomes and the Hallmarks of Cancer.
Huber O; Petersen I
Cell Commun Adhes; 2015; 22(1):15-28. PubMed ID: 26133535
[TBL] [Abstract][Full Text] [Related]
11. Activation of WNT/Beta-Catenin Signaling and Regulation of the Farnesoid X Receptor/Beta-Catenin Complex After Murine Bile Duct Ligation.
Zhang R; Nakao T; Luo J; Xue Y; Cornuet P; Oertel M; Kosar K; Singh S; Nejak-Bowen K
Hepatol Commun; 2019 Dec; 3(12):1642-1655. PubMed ID: 31832572
[TBL] [Abstract][Full Text] [Related]
12. Desmosomes: a role in cancer?
Chidgey M; Dawson C
Br J Cancer; 2007 Jun; 96(12):1783-7. PubMed ID: 17519903
[TBL] [Abstract][Full Text] [Related]
13. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
[TBL] [Abstract][Full Text] [Related]
14. 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways.
Xie XL; Wei M; Kakehashi A; Yamano S; Tajiri M; Wanibuchi H
Toxicol Sci; 2012 Feb; 125(2):392-400. PubMed ID: 22094457
[TBL] [Abstract][Full Text] [Related]
15. Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis.
Pradhan-Sundd T; Zhou L; Vats R; Jiang A; Molina L; Singh S; Poddar M; Russell J; Stolz DB; Oertel M; Apte U; Watkins S; Ranganathan S; Nejak-Bowen KN; Sundd P; Monga SP
Hepatology; 2018 Jun; 67(6):2320-2337. PubMed ID: 29023813
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Wnt Signaling Reduces Cholestatic Injury by Disrupting the Inflammatory Axis.
Ayers M; Kosar K; Xue Y; Goel C; Carson M; Lee E; Liu S; Brooks E; Cornuet P; Oertel M; Bhushan B; Nejak-Bowen K
Cell Mol Gastroenterol Hepatol; 2023; 16(6):895-921. PubMed ID: 37579970
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
18. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
19. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
Kluwe J; Wongsiriroj N; Troeger JS; Gwak GY; Dapito DH; Pradere JP; Jiang H; Siddiqi M; Piantedosi R; O'Byrne SM; Blaner WS; Schwabe RF
Gut; 2011 Sep; 60(9):1260-8. PubMed ID: 21278145
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Kimura M; Nishikawa K; Osawa Y; Imamura J; Yamaji K; Harada K; Yatsuhashi H; Murata K; Miura K; Tanaka A; Kanto T; Kohara M; Kamisawa T; Kimura K
Hepatol Commun; 2022 Oct; 6(10):2732-2747. PubMed ID: 35855613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
